Loading clinical trials...
Loading clinical trials...
An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443
Conditions
Interventions
nusinersen
Locations
47
United States
David Geffen School of Medicine at UCLA
Los Angeles, California, United States
Stanford University School of Medicine
Palo Alto, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
Nemours Children's Clinic
Orlando, Florida, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
New York, Illinois, United States
Start Date
November 4, 2015
Primary Completion Date
August 21, 2023
Completion Date
August 21, 2023
Last Updated
October 22, 2024
NCT05866419
NCT06839469
NCT06321965
NCT07223489
NCT07332702
NCT07265232
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions